Get the Stockscreener App
11.57
2.53%
-0.30
After Hours:
11.63
0.06
+0.52%
Schrodinger Inc stock is traded at $11.57, with a volume of 789.38K.
It is down -2.53% in the last 24 hours and up +2.39% over the past month.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
See More
Previous Close:
$11.87
Open:
$11.7
24h Volume:
789.38K
Relative Volume:
0.60
Market Cap:
$854.16M
Revenue:
$255.87M
Net Income/Loss:
$-103.27M
P/E Ratio:
-8.2004
EPS:
-1.4109
Net Cash Flow:
$12.46M
1W Performance:
-5.86%
1M Performance:
+2.39%
6M Performance:
-39.30%
1Y Performance:
-49.14%
1-Day Range:
$11.38
$11.78
1-Week Range:
$11.38
$12.43
52-Week Range:
$11.11
$27.63
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
11.57 | 876.30M | 255.87M | -103.27M | 12.46M | -1.4109 |
VEEV
Veeva Systems Inc
|
179.11 | 30.45B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
48.83 | 8.78B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.31 | 8.09B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.10 | 6.90B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.03 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Tudor Investment Corp ET AL Has $6.75 Million Position in Schrodinger, Inc. $SDGR - MarketBeat
Transcript : Schrödinger, Inc. Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum, Mar-17-2026 09 - marketscreener.com
Schrodinger Conference: SDGR Targets Hosted Shift, Platform Adoption, EBITDA Profitability in 3 Years - Yahoo Finance
Discipline and Rules-Based Execution in SDGR Response - Stock Traders Daily
Schrödinger (SDGR) Morgan Stanley 22nd Annual Global Healthcare Conference Summary - Quartr
Schrodinger downgraded at Citi after clinical program exit - MSN
Schrödinger updates 2025 software growth guidance to 8%-13% amid pharma scale-up delays and operational efficiency focus - MSN
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 18, 2026 - BioSpace
Schrodinger reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
SDGR: Analyst Michael Yee of UBS Lowers Price Target to $13, Mai - GuruFocus
UBS Group Cuts Schrodinger (NASDAQ:SDGR) Price Target to $13.00 - MarketBeat
Schrödinger at KeyBanc Forum: Strategic Shift to Hosted Contracts By Investing.com - Investing.com South Africa
Schrödinger at KeyBanc Forum: Strategic Shift to Hosted Contracts - Investing.com
SDGR: Strategic shift to hosted software, AI integration, and new products drive growth and industry impact - TradingView
Schrodinger (SDGR) Upgraded to Buy by B of A Securities | SDGR S - GuruFocus
Farallon Capital Management LLC Lowers Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Keybanc Maintains Schrödinger (SDGR) Overweight Recommendation - MSN
Schrödinger slides after early-stage trial data for cancer therapy - MSN
Schrödinger Promotes Therese Abrams to Principal Accounting Officer - The Globe and Mail
Do Options Traders Know Something About Schrodinger Stock We Don't? - MSN
Chemoinformatics Market Is Going to Boom Rapidly | Schrödinger Inc., PerkinElmer Inc., BioSolveIT GmbH - openPR.com
Schrödinger at Leerink Conference: Strategic Growth Amid Transition By Investing.com - Investing.com South Africa
Schrödinger at Leerink Conference: Strategic Growth Amid Transition - Investing.com
Schrodinger2026 Funding Rounds & List of Investors - Tracxn
Jain Rachit, Schrodinger CFO, sells $21k in SDGR stock By Investing.com - Investing.com Nigeria
SDGR: Transition to ACV, new product launches, and materials science drive growth outlook - TradingView
SDGR: Transition to ACV, new product launches, and materials science expansion drive future growth - TradingView
Behavioral Patterns of SDGR and Institutional Flows - Stock Traders Daily
Transcript : Schrödinger, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 01 - marketscreener.com
Schrodinger Stock: Navigating Market Pressure Through Operational Discipline () - aktiencheck.de
Citigroup Downgrades Schrödinger (SDGR) - MSN
Does Schrodinger (SDGR) Have the Potential to Rally 40.43% as Wall Street Analysts Expect? - MSN
Jain Rachit, Schrodinger CFO, sells $21k in SDGR stock - Investing.com
Schrödinger Earnings Call: Growth Amid Hosted Transition - TipRanks
Ramy Farid Sells 3,661 Shares of Schrodinger (NASDAQ:SDGR) Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) Insider Sells $16,653.00 in Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) Insider Karen Akinsanya Sells 1,366 Shares - MarketBeat
Schrodinger (NASDAQ:SDGR) CFO Sells $21,039.90 in Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) EVP Kenneth Patrick Lorton Sells 1,222 Shares - MarketBeat
How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets - Yahoo Finance
Citigroup Inc. Grows Stake in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger, Inc. $SDGR Shares Sold by ARK Investment Management LLC - MarketBeat
[144] Schrodinger, Inc. SEC Filing - Stock Titan
Vanguard Group Inc. Has $127.16 Million Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger (NASDAQ: SDGR) CEO gets options, sells shares under 10b5-1 - Stock Titan
Schrodinger (SDGR) CFO receives new stock options and RSU grants - Stock Titan
Schrodinger (NASDAQ: SDGR) EVP granted stock options and RSU awards - Stock Titan
Schrodinger (NASDAQ: SDGR) CTO Lorton receives new stock and option awards - Stock Titan
Schrodinger (SDGR) CAO Jenny Herman receives new RSU and option awards - Stock Titan
Schrodinger (SDGR) executive granted 48,500 options and sells shares for taxes - Stock Titan
Equity grants to Schrodinger (NASDAQ: SDGR) officer include options and RSUs - Stock Titan
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.50%
2.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):